Compare Mercadolibre Inc (MELI) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mercadolibre Inc vs Tenet Healthcare Corporation — how do they compare? Mercadolibre Inc trades at $1,924.05 (market cap $92.49B), while Tenet Healthcare Corporation trades at $259.45 (market cap $20.93B). The key difference: Mercadolibre Inc is far larger — about 4.4× Tenet Healthcare Corporation's market cap, and Mercadolibre Inc is trading nearer its 52-week high, Tenet Healthcare Corporation nearer its low. Which is the better fit depends on your goals.
| MELI | THC | |
|---|---|---|
Market Cap | $92.49B | $20.93B |
Sector | Consumer Cyclical | Health |
52-Week High | $2.51K | $262.63 |
52-Week Low | $1.55K | $161.37 |
Enterprise Value | $100.14B | $32.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MercadoLibre (MELI) trades at $1,820.69, down 0.51% in the last 24 hours, with a bearish technical signal. The stock shows strong revenue growth, with Q2 2026 EPS beating estimates at $9.19 versus $8.65 expected, but recent quarters have missed expectations. Valuation ratios like P/E of 49.53 are elevated, while profitability metrics include a 42.68% gross margin and 27.5% ROE. Analyst consensus is strongly bullish with a $2,020 price target, but technical indicators suggest near-term weakness.
Outlook remains positive long-term due to robust e-commerce and fintech expansion in Latin America, with revenue projected to hit $35.2B in 2026. Risks include margin pressures from heavy investments and competitive threats. The stock offers growth potential if profit trends improve, but investors face volatility from strategic spending and market sentiment shifts.
Tenet Healthcare (THC) trades at $262.13, up 2.14% with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with Q2 2026 EPS beating estimates at $6.12 versus $4.26 expected, while valuation metrics remain attractive with P/E of 10.05 and EV/EBITDA of 5.74. Recent institutional buying and positive earnings revisions support the upward trend.
Outlook remains positive with consensus price target of $281.44 offering 7.4% upside potential. Key risks include healthcare policy headwinds and competitive pressures, but strong ambulatory growth and expense management provide fundamental support. The stock presents a compelling value-growth combination for investors seeking healthcare exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mercadolibre Inc
MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Read more on MELI →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
